
Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice
Author(s) -
Cristina Casanova-Martínez,
Elena Yaiza Romero-Ventosa,
Sonia González-Costas,
Cecilia Arroyo-Conde,
Guadalupe Piñeiro-Corrales
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.188292
Subject(s) - gemcitabine , medicine , regimen , neutropenia , nausea , oncology , pancreatic cancer , nab paclitaxel , adverse effect , vomiting , paclitaxel , observational study , retrospective cohort study , toxicity , surgery , cancer
Pancreatic cancer in a common tumor in our country for which there are various treatment alternatives.